Status:
WITHDRAWN
Protein and microRNA Markers for Early Detection of Alzheimer's Disease
Lead Sponsor:
Sun Yat-sen University
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
30-80 years
Brief Summary
Blood will be harvested from three groups of people, normal control, patients with mild cognitive impairment (MCI) and patients with Alzheimer's disease (AD), 20 people per group. The blood samples wi...
Detailed Description
As discussed above, patients' blood samples will be tested by chip to test microRNA expression and liquid chromatography-mass spectrometry to determine protein expression. The differences in microRNA ...
Eligibility Criteria
Inclusion
- Age-matched with patients with MCI group
Exclusion
- With cognitive dysfunction
- With major cardiovascular diseases, especially stroke and brain transient ischemic attack
- On steroid treatment
- with major organ diseases
Key Trial Info
Start Date :
December 7 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03388242
Start Date
December 7 2017
End Date
March 30 2020
Last Update
June 23 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Third Affiliated Hospital of Sun Yat-Sen University
Guangzhou, Guangdong, China, 510000
2
Sun Yat-Sen Memorial Hospital
Guangzhou, Guangdong, China, 510120